LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX)

31 filings reported holding LVTX - LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share as of Q4 2024.
LAVA Therapeutics NV - Common shares, Euro 0.12 nominal value per share (LVTX) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 6.47M shares of 26.3M outstanding shares and own 24.59% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (2.07M shares), Sanofi (1.92M shares), Merck & Co., Inc. (1.15M shares), Bruce & Co., Inc. (772K shares), SPHERA FUNDS MANAGEMENT LTD. (126K shares), Pathway Financial Advisors LLC (103K shares), PNC Financial Services Group, Inc. (65K shares), TWO SIGMA INVESTMENTS, LP (48.8K shares), BNP PARIBAS FINANCIAL MARKETS (41.8K shares), and Engineers Gate Manager LP (32K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.